Recordati acquires trio of Bayer consumer brands

 

 

International pharmaceutical group Recordati has announced the purchase of three Bayer Consumer Health brands for the French market: Transipeg®, TransipegLib® and Colopeg®.

The 2016 net sales of the products in France amount to around €10 million.

Transipeg® and TransipegLib® are macrogol based laxatives for the treatment of symptomatic constipation in adults and Colopeg® is a large volume bowel cleanser indicated in preparation for endoscopic exploration.

Andrea Recordati, CEO and Vice Chairman, said: "We are progressively enhancing our presence in the area of gastroenterology and this line of products provides further product choice for doctors and patients in order to meet their specific needs."

 

 

Make a comment

To voice your opinion, please Log in or Register.